6 completed, 1 terminated, 1 unknown. 3 Phase 2, 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Pneumonia, Staphylococcal: new trials by email Literature Review of Pneumonia, Staphylococcal trials Research Report on Pneumonia, Staphylococcal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vancomycin Dosage Strategy Based on a Trough Concentration Model Individualized therapy - Pneumonia, Staphylococcal | Phase 4 | Completed | Peking University Third Hospital | 66 | 2019-10-01 | 2022-08-31 |
| Mucoid Staphylococcus Aureus in Cystic Fibrosis Airways Staphylococcus Aureus Pneumonia, Lung Diseases | Completed | University Hospital Muenster | 628 | 2019-03-01 | 2023-02-02 | |
| Epidemiology of Post-influenza Bacterial Pneumonia Due to a Panton-Valentine Leukocidin Positive Staphylococcus Aureus Influenza, Staphylococcus Aureus Pneumonia | Unknown | Central Hospital, Nancy, France | 35 | 2017-10-01 | 2017-12-11 | |
| Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus. ASN100, Placebo - Pneumonia, Ventilator-associated, Pneumonia, Staphylococcal | Phase 2 | Terminated | Arsanis, Inc. | 155 | 2016-11-01 | 2019-07-31 |
| Study of the Efficacy and Safety of MEDI4893 MEDI4893, Placebo - Staphylococcus Aureus Pneumonia | Phase 2 | Completed | MedImmune LLC | 213 | 2014-10-10 | 2019-12-23 |
| Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation Vancomycin - Pneumonia, Staphylococcal, Methicillin-Resistant Staphylococcus Aureus | Phase 2 | Completed | Seoul National University Hospital | 20 | 2013-08-01 | 2019-04-23 |
| Panton Valentine Leucocidin Serum and Blood samples - Staphylococcus Aureus Pneumonias | Not applicable | Completed | Hospices Civils de Lyon | 234 | 2011-05-01 | 2025-09-09 |
| Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) linezolid (Zyvox), vancomycin - Methicillin Resistant Staphylococcus Aureus (MRSA) | Phase 4 | Completed | Pfizer | 1225 | 2004-10-01 | 2012-02-01 |
Pneumonia (4) · Staphylococcal Infections (4) · Cystic Fibrosis (1) · Healthcare-Associated Pneumonia (1) · Influenza, Human (1) · Lung Diseases (1) · Pneumonia, Ventilator-Associated (1) · Respiratory Insufficiency (1)
Bacterial Infections (8) · Bacterial Infections and Mycoses (8) · Gram-Positive Bacterial Infections (8) · Infections (8) · Pneumonia, Bacterial (8) · Respiratory Tract Diseases (8) · Respiratory Tract Infections (8) · Lung Diseases (7) · Pneumonia (4) · Staphylococcal Infections (4) · Cross Infection (2) · Disease Attributes (2) · Iatrogenic Disease (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Vancomycin (3) · ASN100 (1) · BID protein, human (1) · Blood Specimen Collection (1) · Inhalation (1) · Linezolid (1) · suvratoxumab (1)
Arsanis, Inc. (1) · Central Hospital, Nancy, France (1) · Hospices Civils de Lyon (1) · MedImmune LLC (1) · Peking University Third Hospital (1) · Pfizer (1) · Seoul National University Hospital (1) · University Hospital Muenster (1)
France (5) · Germany (3) · Portugal (3) · Spain (3) · United States (3) · Austria (2) · Belgium (2) · Czechia (2) · Greece (2) · Hungary (2) · Poland (2) · Russia (2) · South Africa (2) · South Korea (2) · Argentina (1)
Barbara C Kahl, MD (1) · Jae-Joon Yim, MD (1) · Qingtao Zhou, Dr. (1)
PMID 24011955, PMID 24279701, PMID 26196695, PMID 27600290, PMID 27795368, PMID 32050447, PMID 33894131, PMID 39918841
2016 (1)